Agiliti (AGTI) Expected to Beat Earnings Estimates: Should You Buy?

Core Viewpoint - Agiliti (AGTI) is anticipated to report a year-over-year decline in earnings despite an increase in revenues, with the upcoming earnings report expected on March 5, 2024 [1] Financial Expectations - The consensus estimate for Agiliti's quarterly earnings is $0.12 per share, reflecting a year-over-year decrease of 33.3% [2] - Expected revenues for the quarter are $291.99 million, which is a 3.7% increase from the same quarter last year [2] Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analysts' assessments [3] - A positive Earnings ESP of +1.70% suggests that analysts have recently become more optimistic about Agiliti's earnings prospects [6] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [5] - Agiliti currently holds a Zacks Rank of 3, indicating a neutral outlook [6] Historical Performance - In the last reported quarter, Agiliti was expected to earn $0.10 per share but only achieved $0.09, resulting in a surprise of -10% [7] - Over the past four quarters, Agiliti has only beaten consensus EPS estimates once [7] Industry Comparison - GoodRx Holdings, Inc. (GDRX), another player in the medical services industry, is expected to report earnings of $0.08 per share, representing a year-over-year increase of 14.3% [9] - GoodRx has an Earnings ESP of 17.39% and a Zacks Rank of 2, suggesting a strong likelihood of beating consensus EPS estimates [9]